TBXU
Direxion Daily Biotech Top 5 Bull 2X ETFNYSE
Updated 1 day ago
Coverage building
$35.65-3.69%
Close Oct 13, 2026
- Market cap
- —
- 1 month
- -9.3%
- 3 months
- +12.4%
- 1 year
- +35.6%
- 52-week range
- $27.02$45.85
- Dividend, last 12 mo
- $0.352 · 0.99% yield
- Last ex-date
- Sep 22, 2026 · $0.142
- Short interest
- 262 sharessettled Sep 30, 2026 · -92.2% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if TBXU is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Institutional coverage is still building for this ticker.
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
4 filers reported a long position in TBXU for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| GOLDMAN SACHS GROUP INC | $803.1K | 25K | Unchanged |
| BANK OF AMERICA CORP /DE/ | $803.1K | 25K | Unchanged |
| GTS SECURITIES LLC | $441.5K | 13.7K | -10% |
| UBS Group AG | $22.7K | 706 | New |
Get the Full Analysis for TBXU
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.